NicOx Gets EMEA Validation of Naproxcinod MAA Submission

NicOx S.A. announced that the European Medicines Agency (EMEA) has validated the Marketing Authorization Application (MAA) for naproxcinod, which was submitted through the centralized procedure in December 2009.
TradingMarkets